10-K Filing

MEDICAL INNOVATION HOLDINGS, INC. CIK: 1093248 FY 2017

Filing Information

Form Type	10-K
Accession Number	`0001493152-17-007957`
Period End Date	20170430
Filing Date	20170719
Fiscal Year	2017
Fiscal Period	FY
XBRL Instance	mihi-20170430.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 34 Income Statement 24 Cash Flow Statement 30 Stockholders Equity 11

Balance Sheet 34 line items

Line Item	Tag	Value	Unit	Period
Cash	`CashAndCashEquivalentsAtCarryingValue`	$8.89K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$1.60K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Total current assets	`AssetsCurrent`	$8.89K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.60K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$8.89K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.60K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$203.64K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$804.85K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Notes payable	`NotesPayableCurrent`	$322.21K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$441.93K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	37.21M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	39.18M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	39.18M	shares	Point-in-time
Short term debt	`ShortTermBorrowings`	$18.10K	USD	Point-in-time
Short term debt	`ShortTermBorrowings`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	37.21M	shares	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$663.67K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.13M	USD	Point-in-time
Common stock, $0.0001 par value, 500,000,000 common shares authorized, 39,175,022 and 37,209,022 issued and outstanding on April 30, 2017 and April 30, 2016, respectively	`CommonStockValue`	$3.92K	USD	Point-in-time
Common stock, $0.0001 par value, 500,000,000 common shares authorized, 39,175,022 and 37,209,022 issued and outstanding on April 30, 2017 and April 30, 2016, respectively	`CommonStockValue`	$3.72K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$440.86K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$-3.72K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.56M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-662.07K	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-3.10M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-662.07K	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.12M	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$8.89K	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$1.60K	USD	Point-in-time

Income Statement 24 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	-	USD	Annual
Revenues	`Revenues`	-	USD	Annual
Gross profit	`GrossProfit`	-	USD	Annual
Gross profit	`GrossProfit`	-	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	-	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$840.54K	USD	Annual
Asset impairment	`AssetImpairmentCharges`	$662.07K	USD	Annual
Asset impairment	`AssetImpairmentCharges`	-	USD	Annual
Total operating expenses	`OperatingExpenses`	-	USD	Annual
Total operating expenses	`OperatingExpenses`	$840.54K	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$662.07K	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$840.54K	USD	Annual
Total other expenses	`OtherNonoperatingIncomeExpense`	-	USD	Annual
Total other expenses	`OtherNonoperatingIncomeExpense`	$60.32K	USD	Annual
Net Income (Loss)	`NetIncomeLoss`	$-900.87K	USD	Annual
Net Income (Loss)	`NetIncomeLoss`	$-662.07K	USD	Annual
Basic	`EarningsPerShareBasic`	$-0.02	USD	Annual
Basic	`EarningsPerShareBasic`	$-0.02	USD	Annual
Diluted	`EarningsPerShareDiluted`	$-0.02	USD	Annual
Diluted	`EarningsPerShareDiluted`	$-0.02	USD	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	38.36M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	37.21M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.21M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	38.36M	shares	Annual

Cash Flow Statement 30 line items

Line Item	Tag	Value	Unit	Period
Net loss attributable to common stockholders	`NetIncomeLoss`	$-900.87K	USD	Annual
Net loss attributable to common stockholders	`NetIncomeLoss`	$-662.07K	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-16.50K	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$601.21K	USD	Annual
Stock issued for services	`IncreaseDecreaseInStockIssuedForServices`	-	USD	Annual
Stock issued for services	`IncreaseDecreaseInStockIssuedForServices`	$149.31K	USD	Annual
Notes payable and short term debt	`IncreaseDecreaseInNotesPayableCurrent`	$-165.81K	USD	Annual
Notes payable and short term debt	`IncreaseDecreaseInNotesPayableCurrent`	-	USD	Annual
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-16.50K	USD	Annual
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-316.15K	USD	Annual
Net cash (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	Annual
Net cash (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	Annual
Decrease in Notes Payable and short term debt	`DecreaseInNotesPayableAndShortTermDebt`	$-18.10K	USD	Annual
Decrease in Notes Payable and short term debt	`DecreaseInNotesPayableAndShortTermDebt`	-	USD	Annual
Increase in notes payable	`IncreaseInNotesPayable`	$46.09K	USD	Annual
Increase in notes payable	`IncreaseInNotesPayable`	-	USD	Annual
Issuance of Common Stock	`ProceedsFromIssuanceOfCommonStock`	$295.46K	USD	Annual
Issuance of Common Stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Due to Shareholders	`ProceedsFromRelatedPartyDebt`	-	USD	Annual
Due to Shareholders	`ProceedsFromRelatedPartyDebt`	$18.10K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$323.45K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$18.10K	USD	Annual
NET CHANGE IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$7.29K	USD	Annual
NET CHANGE IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.60K	USD	Annual
CASH, Beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$8.89K	USD	Point-in-time
CASH, Beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.60K	USD	Point-in-time
CASH, Beginning of year	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
CASH, Ending of year	`CashAndCashEquivalentsAtCarryingValue`	$8.89K	USD	Point-in-time
CASH, Ending of year	`CashAndCashEquivalentsAtCarryingValue`	$1.60K	USD	Point-in-time
CASH, Ending of year	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time

Stockholders Equity 11 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-3.10M	USD	Point-in-time
Balance	`StockholdersEquity`	$-662.07K	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.12M	USD	Point-in-time
Shares issued on reverse merger	`StockIssuedDuringPeriodValueAcquisitions`	-	USD	Annual
Recapitalization of shares	`StockIssuedDuringPeriodValueOther`	-	USD	Annual
Issuance of shares	`StockIssuedDuringPeriodValueNewIssues`	$444.77K	USD	Annual
Net loss	`NetIncomeLoss`	$-900.87K	USD	Annual
Net loss	`NetIncomeLoss`	$-662.07K	USD	Annual
Balance	`StockholdersEquity`	$-3.10M	USD	Point-in-time
Balance	`StockholdersEquity`	$-662.07K	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.12M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.